These novel treatments, Tirzepatide , represent a groundbreaking advancement in treating obesity and potentially associated conditions . These drugs are classified as GLP-1 receptor agonists , meaning https://oisiwvdp434897.blogprodesign.com/62782743/tirzepatide-a-thorough-examination-into-metabolic-copyright